The Landmark ELSA-Brasil Study Unveils Troubling Links

Researchers from the University of São Paulo and collaborating institutions in Brazil have published a pivotal prospective study in the journal Neurology, examining the long-term effects of low- and no-calorie sweeteners (LNCSs), commonly known as artificial sweeteners, on brain health. Drawing from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), a large cohort of civil servants, the investigation tracked 12,772 participants with an average age of 52 years over approximately eight years, from 2008 to 2019. Participants completed detailed food frequency questionnaires at baseline, reporting their intake of seven specific LNCSs over the previous year. Cognitive function was rigorously assessed at baseline, midpoint, and follow-up using standardized tests for verbal fluency, working memory, word recall, processing speed, and overall cognition, yielding z-scores for global cognitive performance and specific domains like memory and executive function.

After adjusting for confounders such as age, sex, education, hypertension, diabetes, cardiovascular disease, and physical activity, the analysis revealed a dose-dependent association: those in the highest tertile of LNCS consumption (average 191 mg/day) experienced a 62% faster decline in global cognition compared to the lowest tertile (20 mg/day), equivalent to accelerating brain aging by about 1.6 years. The middle tertile showed a 35% faster decline, akin to 1.3 years of additional aging. This pattern held particularly strong for declines in memory and verbal fluency.

Specific Sweeteners Under Scrutiny: Aspartame, Saccharin, and More

Individual analyses pinpointed six of the seven sweeteners as problematic. Aspartame, found in diet sodas and sugar-free yogurts, saccharin (e.g., Sweet'N Low packets), acesulfame potassium (Ace-K, common in energy drinks and chewing gum), and sugar alcohols like erythritol (in keto bars and Truvia blends), sorbitol (sugar-free candies), and xylitol (mints and oral care products) were each linked to accelerated declines in global cognition, memory, and verbal fluency. Notably, tagatose—a rarer LNCS—showed no such association.

• Aspartame: Breaks down into methanol, aspartic acid, and phenylalanine; implicated in neuroinflammation in animal models.
• Saccharin: Oldest artificial sweetener, linked to memory lapses in prior rodent studies.
• Acesulfame-K: Often blended with other sweeteners; potential glucose metabolism disruptor.
• Erythritol and sugar alcohols: Fermented by gut bacteria, possibly altering microbiota and blood-brain barrier permeability.

For context, the highest intake of aspartame in the study equated to roughly one can of diet soda daily, while sorbitol averaged 64 mg/day in top consumers.

Vulnerable Populations: Middle-Aged Adults and Diabetics

The cognitive risks were most pronounced in participants under 60 years old, where high LNCS intake hastened verbal fluency and global cognition declines. In those over 60, no significant links emerged, possibly due to ceiling effects in cognitive testing or differing brain reserve. Diabetics faced amplified dangers, with faster memory and global declines, likely compounded by disease-related vascular damage and higher sweetener reliance for glycemic control. In the U.S., where over 38 million adults have diabetes (CDC data), this raises alarms for widespread diet soda and low-sugar product users.

Lead author Claudia Kimie Suemoto, MD, PhD, from the University of São Paulo's Division of Geriatrics, noted, “Low- and no-calorie sweeteners are often seen as a healthy alternative to sugar, however our findings suggest certain sweeteners may have negative effects on brain health over time.”

Unraveling the Mechanisms: From Gut to Brain

While causation remains unproven—this is an observational study—plausible pathways include neuroinflammation, oxidative stress, and gut-brain axis disruption. Aspartame may elevate brain inflammatory markers, while sugar alcohols like erythritol alter gut microbiota, compromising the intestinal barrier and influencing neurotransmitter production (e.g., GABA). Unlike glucose, which fuels 20% of the body's energy needs primarily for the brain, LNCS provide no calories, potentially depriving neurons and mimicking sweetness without satiety signals.

Recent U.S. research echoes this: A University of Miami analysis linked daily diet soda to 34% higher dementia risk, attributing it to vascular effects. CU Boulder's work on erythritol showed brain cell impairment and stroke risk in models.

Photo by Babs Gorniak on Unsplash

American Consumption Patterns and Regulatory Landscape

In the United States, the artificial sweetener market hit $2.23 billion in 2024, projected to reach $4.15 billion by 2033, driven by low-carb diets and diabetes prevalence. Diet sodas account for billions of servings annually, with aspartame and Ace-K ubiquitous. The FDA approves these under acceptable daily intake (ADI) limits—aspartame 50 mg/kg body weight (about 18 cans for 150 lb person)—deeming them safe based on extensive reviews, though recent petitions question aspartame's carcinogenicity (classified 'possibly carcinogenic' by WHO IARC).

FDA High-Intensity Sweeteners page affirms safety for general use, but emerging data prompts scrutiny.

University researchers drive this discourse; for nutrition science careers, check research jobs in higher education.

Expert Perspectives and Study Limitations

Experts like Clifford Segil, DO, suggest LNCS may 'trick' the brain sans glucose fuel, exacerbating issues in metabolic disorders. Keri Gans, RDN, urges moderation, noting unaccounted factors like sleep or exercise. The International Sweeteners Association countered that observational data can't prove causality, citing self-reported diets and potential reverse causation (e.g., early cognitive issues prompting low-sugar choices).

• Self-reported intake prone to recall bias.
• Attrition and selection bias in longitudinal cohorts.
• Not all LNCS tested (e.g., sucralose absent).
• No randomization, residual confounding possible.

Balanced views emphasize need for randomized trials.

Promising Alternatives: Natural Paths to Sweetness

Stevia and monk fruit, plant-derived and GRAS by FDA, show minimal gut disruption in short studies. Moderate honey, maple syrup, or fruit purees provide antioxidants and polyphenols supporting brain health via Mediterranean-style diets. Tagatose, a low-glycemic lactose derivative, emerged unscathed.

Researchers advocate whole foods; explore academic career advice for dietitians.

Actionable Strategies for Cognitive Protection

1. Scan labels: Limit products with aspartame, Ace-K > occasional use.
2. Prioritize whole fruits for sweetness and fiber.
3. Boost brain diet: MIND diet (berries, nuts, greens) slows decline 53% per studies.
4. Exercise 150 min/week; sleep 7-9 hrs.
5. Monitor if diabetic: Consult RD for personalized plans.

For professionals in health sciences, higher ed jobs offer research opportunities.

Photo by ALLAN LAINEZ on Unsplash

Looking Ahead: Public Health and Research Imperatives

As U.S. dementia cases projected to triple by 2060 (Alz Assoc), rethinking LNCS in guidelines is urgent. Universities like São Paulo exemplify global collaboration; U.S. institutions lead follow-ups. Future RCTs and neuroimaging could clarify causality. Until then, moderation prevails for brain longevity.

Engage with professors via Rate My Professor or pursue faculty positions.